Methodist Company Profile
✉ Email this page to a colleague
What is the competitive landscape for METHODIST
METHODIST has three approved drugs.
Drugs and US Patents for Methodist
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Methodist | GALLIUM GA 68 EDOTREOTIDE | gallium ga-68 edotreotide | SOLUTION;INTRAVENOUS | 218845-001 | Oct 10, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Methodist Hosp Res | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203904-001 | Apr 23, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Methodist | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 215083-001 | Jul 9, 2021 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

